Details of the Drug

General Information of Drug (ID: DMI9MYQ)

Drug Name
A-007
Synonyms Bis(4-hydroxyphenyl)methanone (2,4-dinitrophenyl)hydrazone; 4,4'-Dihydrobenzophenone-2,4-dinitrophenylhydrazone
Indication
Disease Entry ICD 11 Status REF
Skin cancer 2C30-2C37 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C19H14N4O6
Canonical SMILES
C1=CC(=CC=C1C(=NNC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C3=CC=C(C=C3)O)O
InChI
1S/C19H14N4O6/c24-15-6-1-12(2-7-15)19(13-3-8-16(25)9-4-13)21-20-17-10-5-14(22(26)27)11-18(17)23(28)29/h1-11,20,24-25H
InChIKey
YOQPCWIXYUNEET-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
3089902
CAS Number
2675-35-6
UNII
XAV05295I5
DrugBank ID
DB05686
TTD ID
D07TZT

References

1 ClinicalTrials.gov (NCT00285207) Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix. U.S. National Institutes of Health.